Towards noncommutative quantum reality.

The implications of the physical theory of quantum mechanics on the question of realism is much a subject of sustaining interest, while the background questions among physicists on how to think about all the theoretical notion and 'interpretation' of the theory remains controversial. Through a careful analysis of the theoretical notions with the help of modern mathematical perspectives, we give here a picture of quantum mechanics, as the basic theory for 'nonrelativistic' particle dynamics, that can be seen as being as much about the physical reality as classical mechanics itself. The key is to fully embrace the noncommutativity of the theory and see it as a notion about the reality of physical quantities.

PRIMUS: Comprehensive proteomics of mouse intervertebral discs that inform novel biology and relevance to human disease modelling.

Mice are commonly used to study intervertebral disc (IVD) biology and related diseases such as IVD degeneration. Discs from both the lumbar and tail regions are used. However, little is known about compartmental characteristics in the different regions, nor their relevance to the human setting, where a functional IVD unit depends on a homeostatic proteome.

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.

Lessons Learned: Treatment with BEZ235 has not been shown to demonstrate increased efficacy compared with everolimus and may be associated with a poorer tolerability profile.The hypothesis of dual targeting of the phosphatidylinositol 3-kinase and mammalian target of rapamycin pathways in patients with advanced pancreatic neuroendocrine tumors may warrant further study using other agents.

Background: This phase II study investigated whether targeting the phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway via PI3K, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) inhibition using BEZ235 may be more effective than mTORC1 inhibition with everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET) who are naïve to mTOR inhibitor therapy.

Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.

Activation of the phosphatidylinositol 3-kinase/mechanistic target of rapamycin pathway plays a role in the pathogenesis of non-Hodgkin lymphoma. This multicenter, open-label phase 2 study evaluated buparlisib (BKM120), a pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or refractory non-Hodgkin lymphoma. Three separate cohorts of patients (with diffuse large B-cell lymphoma, mantle cell lymphoma, or follicular lymphoma) received buparlisib 100 mg once daily until progression, intolerance, or withdrawal of consent.

R-parity violating contribution to the neutron electric dipole moment at one-loop order.

We present the full result for the down squark mass-squared matrix in the complete theory of supersymmetry without R parity where all kinds of R-parity violating terms are admitted without bias using an optimal parametrization. The major result is a new contribution to LR squark mixing, involving both bilinear and trilinear R-parity violating couplings. Among other things, the latter leads to neutron electric dipole moment at one-loop level.